About Prenatal and Newborn Genetic Testing
Prenatal and newborn genetic testing involves genetic testing before and after birth. Prenatal testing helps detect changes in the fetus before birth. It can reduce a couple's uncertainty or help them decide whether to abort a pregnancy in case of conditions such as Down syndrome, trisomy 18, or an open neural tube defect. The procedure includes two blood tests: one in the first trimester and the next in the second trimester. On the other hand, newborn genetic testing is done just after birth to identify genetic disorders.
TechNavio's analysts forecast the Global Prenatal and Newborn Genetic Testing market to grow at a CAGR of 31.91 percent over the period 2014-2019.
Covered in this Report
This report covers the present scenario and the growth prospects of the Global Prenatal and Newborn Genetic Testing market for the period 2015-2019. The Global Prenatal and Newborn Genetic Testing market can be divided into two segments: Diagnostic Techniques and Screening Methods. To calculate the market size, the report considers revenue generated from these segments.
TechNavio's report, the Global Prenatal and Newborn Genetic Testing Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the APAC and EMEA regions; it also covers the Global Prenatal and Newborn Genetic Testing market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.
Key Regions
• Americas
• APAC
• EMEA
Key Vendors
• Agilent Technologies
• Bio-Rad Laboratories
• Illumina
• Sequenom
Market Driver
• Growing Incidences of Fetal Health-related Abnormalities
• For a full, detailed list, view our report
Market Challenge
• Decrease in Fertility Rates
• For a full, detailed list, view our report
Market Trend
• Increase in Number of New Product Launches
• For a full, detailed list, view our report
Key Questions Answered in this Report
• What will the market size be in 2019 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04. Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
05. Introduction
06. Market Landscape
06.1 Market Overview
06.2 Market Size and Forecast
06.3 Five Forces Analysis
07. Market Segmentation by Technology
08. Prenatal Screening Tests
09. Causes and Risk Factors
10. Genetic Disorders before Birth
11. Geographical Segmentation
12. Buying Criteria
13. Market Growth Drivers
14. Drivers and their Impact
15. Market Challenges
16. Impact of Drivers and Challenges
17. Market Trends
18. Trends and their Impact
19. Vendor Landscape
19.1 Competitive Scenario
19.1.1 Key News
19.1.2 Mergers and Acquisitions
19.2 Market Share Analysis 2014
19.3 Other Prominent Vendors
20. Key Vendor Analysis
20.1 Agilent Technologies
20.1.1 Key Facts
20.1.2 Business Overview
20.1.3 Business Segmentation by Revenue 2013
20.1.4 Product Portfolio by Revenue 2013
20.1.5 Business Segmentation by Revenue 2012 and 2013
20.1.6 Geographical Segmentation by Revenue 2013
20.1.7 Business Strategy
20.1.8 Recent Developments
20.1.9 SWOT Analysis
20.2 Bio-Rad Laboratories
20.2.1 Key Facts
20.2.2 Business Overview
20.2.3 Business Segmentation by Revenue 2013
20.2.4 Product Portfolio by Revenue 2013
20.2.5 Business Segmentation by Revenue 2012 and 2013
20.2.6 Geographical Segmentation by Revenue 2013
20.2.7 Business Strategy
20.2.8 Recent Developments
20.2.9 SWOT Analysis
20.3 Sequenom
20.3.1 Key Facts
20.3.2 Business Overview
20.3.3 Business Segmentation by Revenue 2013
20.3.4 Product Portfolio by Revenue 2013
20.3.5 Business Segmentation by Revenue 2012 and 2013
20.3.6 Geographical Segmentation by Revenue 2013
20.3.7 Business Strategy
20.3.8 Recent Developments
20.3.9 SWOT Analysis
20.4 Illumina
20.4.1 Key Facts
20.4.2 Business Overview
20.4.3 Business Segmentation by Revenue 2013
20.4.4 Product Portfolio by Revenue 2013
20.4.5 Business Segmentation by Revenue 2012 and 2013
20.4.6 Geographical Segmentation by Revenue 2013
20.4.7 Business Strategy
20.4.8 Recent Developments
20.4.9 SWOT Analysis
21. Other Reports in this Series
List of Exhibits
Exhibit 1: Market Research Methodology
Exhibit 2: Global Prenatal and New-born Genetic Testing Market 2014-2019 (US$ billion)
Exhibit 3: Global Prenatal and New-born Genetic Testing market Segmentation by Technology
Exhibit 5: Global Prenatal and New-born Genetic Testing Market Segmentation by Technology
Exhibit 6: Global Prenatal and New-born Genetic Testing Market Segmentation by Type of Test
Exhibit 7: Global Diagnostic Techniques Market Segmentation by Type of Test
Exhibit 8: Global Screening Methods Market Segmentation by Type of Test
Exhibit 9: Causes and Risk Factors of Prenatal and New-born Genetic Testing
Exhibit 10: Various Genetic Disorders before Birth
Exhibit 11: Global Prenatal and New-born Genetic Testing Market by Geographical Segmentation 2014
Exhibit 12: Global Incidence of Chromosomal Abnormalities in New-borns
Exhibit 13: Declining Fertility Rates
Exhibit 14: Spontaneous Abortions and Fertility Rates as a Function of Maternal Age
Exhibit 15: Risks of Down Syndrome and Chromosomal Abnormalities at Live Birth, According to Maternal Age
Exhibit 16: Agilent Technologies: Business Segmentation by Revenue 2013
Exhibit 17: Agilent Technologies: Business Segmentation by Revenue 2012 and 2013
Exhibit 18: Agilent Technologies: Sales by Geography 2013
Exhibit 19: Bio-Rad Laboratories: Business Segmentation by Revenue 2013
Exhibit 20: Bio-Rad Laboratories: Business Segmentation by Revenue 2012 and 2013
Exhibit 21: Bio-Rad Laboratories: Sales by Geography 2013
Exhibit 22: Sequenom: Business Segmentation by Revenue 2013
Exhibit 23: Sequenom: Business Segmentation by Revenue 2012 and 2013
Exhibit 24: Sequenom: Sales by Geography 2013
Exhibit 25: Illumina: Business Segmentation by Revenue 2013
Exhibit 26: Illumina: Business Segmentation by Revenue 2012 and 2013
Exhibit 27: Illumina: Sales by Geography 2013
